Correlation Analysis
Johnson & Johnson vs Regeneron Pharmaceuticals Inc
JNJ vs REGN
-0.148
Weak inverse
When one moves up, the other tends to move down.
Johnson & Johnson
↗JNJ
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Market cap 580.4B
Regeneron Pharmaceuticals Inc
↗REGN
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
Market cap 80.7B · 15,410 employees
Time Series
Relative Performance
Who Moves First
REGN leads JNJ by 6 days
REGN tends to move before JNJ.
After testing 13 timing shifts, the strongest relationship was -0.167 (they moved in opposite directions).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.217
13 periods · Return correlation when both series rose
Both Falling
+0.444
9 periods · Return correlation when both series fell
Diverging
-0.618
13 periods · Return correlation when series moved apart
R-Squared
2.2%
Share of variance in one series explained by the other.
Trend Agreement
64.6%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,254
Deep shared window — 1,254 usable pairs.
Significance
p < 0.001
95% CI: [-0.202, -0.094]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,254 paired data points survived the daily window.
Raw input
1,254
1,254
Normalized
1,254
1,254
Prepared
1,254
1,254
Aligned
1,254
1,254
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
0
A: 0 / B: 0
Series A
Johnson & Johnson
JNJ
Market cap 580.4B
Stock · 1,254 raw → 1,254 prepared
Series B
Regeneron Pharmaceuticals Inc
REGN
Market cap 80.7B · 15,410 employees
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
42
Estimated crossover points between normalized spreads.
Slope
-1.1813
Linear regression slope.
Intercept
932.8082
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
JNJ
Johnson & Johnson
Highest
+0.943
Sandisk Corporation Common Stock
SNDK · 281 data points
Lowest
-0.621
Kimberly-Clark Corp.
KMB · 1,254 data points
REGN
Regeneron Pharmaceuticals Inc
Highest
+0.487
Exxon Mobil Corporation
XOM · 1,254 data points
Lowest
-0.331
Tesla, Inc. Common Stock
TSLA · 1,254 data points
Saved 7 hours ago · ID: stock-jnj-vs-stock-regn-daily